The United States Patent and Trademark Office (USPTO) is considering a new rule that would make it harder for biosimilar manufacturers and patient advocacy groups to challenge drug patents through…
News Nov 14, 2025With President Trump’s GLP-1 pricing deals dominating headlines, the ongoing Medicare negotiation program appears to have taken a backseat — despite the fact that the second round of maximum fair…
News Nov 7, 2025From the Oval Office on Thursday, President Trump announced lower prices on several blockbuster weight-loss drugs, including Ozempic, Wegovy, and Zepbound, for patients on Medicare, as well as for…
Press Releases Nov 6, 2025The White House announced agreements today with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices of their blockbuster weight-loss drugs Ozempic, Wegovy, and Zepbound for patients…
News Oct 31, 2025The FDA took a significant step in accelerating biosimilar approvals this week, announcing a new draft guidance to cut unnecessary red tape and streamline duplicative clinical trial requirements.
Press Releases Oct 29, 2025In response to today’s announcement from the Food and Drug Administration (FDA) on new draft guidance to accelerate biosimilar approvals, Patients For Affordable Drugs Now executive director Merith…
News Oct 24, 2025The re-score of the ORPHAN Cures Act by the Congressional Budget Office (CBO) confirmed what patients feared: the bill is even more expensive and more harmful than originally projected.
Press Releases Oct 23, 2025What was once a $5 billion Big Pharma giveaway has exploded to $8.8 billion – a windfall for drug corporations at the expense of patients and taxpayers.
Press Releases Oct 20, 2025What was once a $5 billion Big Pharma giveaway has exploded to $8.8 billion – a windfall for drug corporations at the expense of patients and taxpayers.
News Oct 17, 2025The Trump administration announced that AstraZeneca struck a deal to sell certain drugs to Medicaid at a discount, and committed to listing any new drugs it releases on the TrumpRx platform.
1:49 · Watch on YouTube
3:50 · Watch on YouTube
0:51 · Watch on YouTube
